Canaanの空売り状況は、投資家がCanaanの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Canaan (NASDAQ:CAN) 株価情報, 空売り情報

CANAAN INC

Canaan

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Canaan Inc

Can B Corp

Tema Oncology ETF

Teucrium Sugar Fund ETV

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma Ltd

Cango Inc. American Depositary Shares, each representing two (2) Class A Ordinary Shares

Cango Inc

CannLabs Inc

Trees Corp

CALIFORNIA NANOTECHS CORP by California Nanotechnologies Corp

California Nanotechnologies Corp

Cano Health Inc Ordinary Shares - Class A

Cano Health Inc Warrants (03/06/2026)

Cian PLC

Calamos Nasdaq Equity & Income ETF

CANAQUEST MED CORP by CanaQuest Medical Corporation

CanaQuest Medical Corp

CANARE ELECTRIC CO LTD by CANARE ELECTRIC CO LTD

Canare Electric Co Ltd

WILLOW BIOSCIENCES INC by Willow Biosciences Inc.

Willow Biosciences Inc

CAVENDISH HYDROGEN ASA by CAVENDISH HYDROGEN ASA

WIIM

ALAB

Astera Labs shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.

<h2 class="wp-block-heading">Zinger Points:</h2>
<ul class="wp-block-list">
<li>Chime reports a $13 million Q1 profit after narrowing 2024 net loss to $25 million — a </li>
<li>Some 76% of Chime's revenue still comes from interchange fees despite efforts to diversify.</li>
<li>With $518 million in 2024 marketing spend, Chime doubles down on Gen Z growth ahead of IPO.</li>
</ul>
Digital banking disruptor Chime has filed for an IPO, positioning itself as the first major fintech to test public markets after a period of market uncertainty, particularly influenced by President Donald Trump&#8216;s recent tariff policies.&nbsp;
The San Francisco-based neobank reported $518.7 million in revenue and $12.9 million in net income for the first quarter of 2025, a 32% year-over-year increase, according to its <a href="https://www.sec.gov/Archives/edgar/data/1795586/000162828025025059/chimefinancialinc-sx1wq1da.htm">registration statement filed</a> last week with the U.S. Securities and Exchange Commission. While profit dipped slightly from the previous quarter, the company's operational momentum and 8.6 million active members underscore its readiness to go public.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
The IPO, underwritten by Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), could value the company between $20 billion and $25 billion, based on projections in the filing.
The timing is strategic. Chime's IPO comes just weeks after trading platform eToro's successful public debut. Founded in 2012, Chime has raised $2.65 billion from blue-chip investors including SoftBank, General Atlantic, and Tiger Global — a war chest that helped it capture 18 million account holders. Chime's appeal to digital-native, mobile-first users makes its move particularly bold, as it targets a segment that has historically been underserved by traditional banks yet increasingly drives financial innovation.
<h2 class="wp-block-heading">Youth Movement Meets Market Volatility</h2>
According to registration statement, Chime posted $2.1 billion in revenue in 2024 — a 38% increase from the prior year — while narrowing its net loss from $203 million to $25 million. Other metrics also point to strong engagement: 78% of users log in daily, and 43% use its early paycheck access feature.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
But risks loom. While the company hasn&#8217;t disclosed share count or pricing, analysts note Chime's continued dependence on interchange fees — 76% of total revenue in 2024, down from 80% two years earlier — could expose it to regulatory shifts, Forbes reported. Its young user base also maintains lower average balances than traditional bank customers, according to the SEC filing. The company, which plans to list on the Nasdaq under ticker symbol CHYM, is aiming to go public later this year.
<h2 class="wp-block-heading">The Tariff Wildcard</h2>
The IPO landscape showed tentative signs of revival in March, when AI infrastructure firm CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)'s <a href="https://in.benzinga.com/content/45335117/investing-in-coreweave-key-insights-on-the-nvidia-backed-ai-ipo">successful debut</a> broke a prolonged tech listing drought. That momentum stalled abruptly in April, as <a href="https://in.benzinga.com/25/04/44878334/trumps-tariffs-just-slammed-the-ipo-window-shut-for-fintech">Trump's renewed tariff threats</a> on Chinese imports rattled markets. Klarna, StubHub, and initially even Chime, postponed their offerings, according to media reports. Now, Chime's decision to proceed positions it as a test case for whether fintechs can navigate the current geopolitical climate to access public markets. The move comes just weeks after eToro's well-received listing, <a href="https://www.bloomberg.com/news/articles/2025-05-14/trading-platform-etoro-surges-42-after-620-million-upsized-ipo">Bloomberg</a> reported, suggesting cautious optimism may be returning to the sector.
Market observers will be watching how the IPO&#8217;s structure takes shape in the coming weeks, especially given the involvement of bulge-bracket underwriters. As the first fintech to test Wall Street's appetite in this new era of trade tensions, Chime's performance could set the tone for a wave of public offerings — or reinforce investor caution.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
Image: Shutterstock

News

CRWV

Chime Files For IPO, Betting On Gen Z To Power Fintech's Market Comeback

Seagate shares are trading higher after the company approved a $5 billion share buyback,

Ralph Lauren shares are trading higher after the company reported better-than-expected Q4 financial results.

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) with a Buy and raises the price target from $82 to $102.

Price Target

Analyst Ratings

DXCM

Citigroup Maintains Buy on DexCom, Raises Price Target to $102

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $119 to $125.

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $125

Chinese carmaker BYD Company ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) might have stolen the April electric vehicle title in Europe, but markets didn&#8217;t bat an eyelid. Neither did Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares.
<a href="https://www.benzinga.com/25/05/45564693/byd-outsells-elon-musks-tesla-amid-european-plans-shift-into-gear">BYD sold 7,231 battery electric cars (BEVs) in Europe in April</a>, edging out Tesla, which sold 7,165, new figures from JATO Dynamics show. Although the milestone represents a symbolic turning point in the European EV battle, it didn&#8217;t dent investor faith, as Tesla shares gained more than 2% on the day of the news.
It's the first time a Chinese brand has outsold Tesla in Europe's BEV segment, a region where the U.S. automaker has long held the pole position. BYD's ascent has been swift: the company began serious expansion into Europe only in late 2022. 
But markets appear to be betting that it&#8217;s only short-term turbulence for Tesla.
<h1 class="wp-block-heading">ETF Exposure: Why Tesla Still Matters</h1>
Tesla&#8217;s short fall in European rankings will be a speed bump, but for <a href="https://www.benzinga.com/etfs">ETFs tracking the EV and clean energy theme</a>, the larger picture still seems intact. 
Tesla is still a top holding in many of the large ETFs, like the ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>), Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>), and iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>), and today&#8217;s market response indicates that few are heading for the exits.
ARKK continues to hold a significant stake in Tesla (12.95%), relying on its push into autonomous mobility, artificial intelligence, and robotics. The upcoming robotaxi pilot and production of the Cybercab next year are part of ARKK's high-conviction, future-focused strategy. For investors betting on transformative tech, Tesla is still a solid play. The fund was up 1.42% at publication on Thursday.
ETFs like DRIV and IDRV has a wider exposure across the EV supply chain, including traditional automakers, chipmakers and software providers. Tesla is still one of the top holdings in both, but these funds also include companies like NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Toyota Motor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>), and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), which help cushion any Tesla-specific volatility. 
This diversified approach makes it attractive to investors looking to benefit from the EV trend without putting all their chips on one automaker. Interestingly, though, IDRIV has rejigged its portfolio to dedicate the largest percentage distribution to BYD. Both the funds were fairly non-reactive to the news today.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/05/45557873/tesla-bull-dan-ives-thinks-elon-musks-ev-giant-could-be-entering-a-golden-era-says-2-trillion-market-cap-on-the-table">Tesla Bull Dan Ives Thinks Elon Musk&#8217;s EV Giant Could Be Entering A &#8216;Golden Era,&#8217; Says 2 Trillion Market Cap &#8216;On The Table&#8217;</a>
<h1 class="wp-block-heading">Short-Term Wobble, Long-Term Vision</h1>
Tesla&#8217;s recent delivery downturn, continuing production interruptions and waiting for updated models such as the new Model Y have caused short-term headwinds. 
The stock is down more than 9% so far this year on an aggregate. Nevertheless, the company&#8217;s long-term strategy, backed by robotaxis, AI-based innovations, energy storage and next-generation vehicle platforms, is still compelling. Tesla&#8217;s pilot robotaxi launch will start as early as June in Austin, while a larger commercial fleet (Cybercab) is scheduled for 2026. 
For ETFs such as ARKK, which are constructed on narratives of innovation, Tesla still fits the thesis.
<h1 class="wp-block-heading">BYD&#8217;s Rise = A Diversification Opportunity</h1>
BYD&#8217;s increasing foothold in Europe, despite the tariffs on Chinese manufacturers imposed by the European Union, underscores the need for geographic diversification across EV ETFs. Funds like KraneShares Electric Vehicles and Future Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KARS#NYSE">KARS</a>), which encompass both Western and Chinese carmakers, are uniquely positioned to capitalize on the worldwide nature of EV growth. BYD is also growing rapidly, doubling international sales in April on a year-over-year basis, and establishing manufacturing platforms in Hungary and Turkey to circumvent EU import tariffs.
<h1 class="wp-block-heading">ESG Considerations And Musk&#8217;s Shadow</h1>
Tesla CEO Elon Musk, remains a magnet for attention, some of it unwanted. Protests and controversy surrounding his politics have generated backlash in the U.S. and Europe, creating an overhang for ESG-oriented funds. Nevertheless, for most ETFs, the firm&#8217;s role in electrification and renewable energy exceeds the reputation risk, at least in the short term.
<h1 class="wp-block-heading">Room To Grow</h1>
Tesla&#8217;s affordability, volume expansion, and capital-free manufacturing focus is unbroken. The firm is targeting lower-cost models and expanding production with minimal incremental capital, aiming for a 60% uplift ratio over 2024 levels. Its energy segment is also picking up, with record Powerwall installations and expanding margins.
<h1 class="wp-block-heading">Conclusion</h1>
BYD&#8217;s passing of Tesla in Europe&#8217;s EV rankings is news-worthy, but not necessarily the turning point. ETF investors and the broader market seem to be seeing through the noise and concentrating on fundamentals. Tesla might be facing choppy waters today, but it remains an ETF pick and is at the center of the future of mobility and innovation.
As the EV industry continues to grow, ETFs that accept Tesla&#8217;s long-term vision along with the emergence of legitimate challengers such as BYD might be the most balanced way to go.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45570155/new-usng-etf-targets-natural-gas-infrastructure-amid-rising-energy-demand">Amplify, Samsung Launch Natural Gas ETF To Power Up AI-Era Infrastructure Boom</a></li>
</ul>

Sector ETFs

Global

Trading Ideas

ETFs

AAPL

ARKK

BYDDY

DRIV

IDRV

KARS

NVDA

TSLA

BYD Outsells Tesla In Europe, But These ETFs Still Back Elon's EV Empire

Shares of Urban Outfitters Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) rallied after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45553566/urban-outfitters-shares-rally-on-record-q1-revenues-details">first-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
JPMorgan On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reiterated an Overweight rating while raising the price target from $63 to $78.
Urban Outfitters reported quarterly earnings of $1.16 per share, 38% above Street expectations of 84 cents per share, Boss said in a note. He added that the outperformance was driven by same-store-sales growth of 5%, coming in above expectations of 3.4%, and adjusted gross margin expansion of 240 (basis points) bps year-on-year to 36.8%.
The quarter's same-store-sales growth "included positive comp growth across all three banners," which has happened for the first time in three years, the analyst wrote. For the second quarter, management guided to high-single-digit percentage growth in consolidated sales growth, with mid-single-digit percentage growth in same-store sales, above Street's 3.4% projection, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Telsey Advisory Group On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5888c53977f9dd0001877a22/dana-telsey">Analyst Dana Telsey</a> maintained a Market Perform rating, while lifting the price target from $59 to $72.
Telsey said that Urban Outfitters' adjusted earnings grew to $1.16 per share from 69 cents per share in the same quarter last year. Total sales grew 10.7% to $1.330 billion, surpassing consensus of 7.6% to $1.292 billion, she added.  
"After a solid finish to FY24, momentum continued into FY25 with a healthy beat across the board in the first quarter," the analyst wrote. The second-quarter guidance was "encouraging," given the challenging macro environment, as it reflects "continued topline momentum across brands along with margin expansion and earnings growth," she further stated. &nbsp;
URBN Price Action: Shares of Urban Outfitters had risen by 22.01% to $72.72 at the time of publication on Thursday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> Urban Outfitters Navigates Tariff Headwinds With Diversification Strategies: No Country &#8216;Accounts For More Than 25%&#8217; Of Production</a></li>
</ul>
Photo: Vladislav Gajic/Shutterstock

Analyst Color

Earnings Beats

Reiteration

Movers

URBN

Urban Outfitters Surges After Q1 Beat: Analysts Highlight Margin Strength, Sales Momentum

Newmark Group, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NMRK#NASDAQ">NMRK</a>) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces the company arranged a $7.1 billion construction loan for Blue Owl Capital, Inc., Crusoe and Primary Digital Infrastructure. The loan, provided by a consortium led by J.P. Morgan, will fund the second phase of a <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4434036-1&amp;h=2693766533&amp;u=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2025%2F05%2F21%2F3085765%2F0%2Fen%2FCrusoe-Blue-Owl-Capital-and-Primary-Digital-Infrastructure-Enter-Second-Phase-of-15-Billion-Joint-Venture-to-Fund-AI-Data-Center-in-Abilene-Texas.html&amp;a=%2415+billion+joint+venture">$15 billion joint venture</a> to fund a 1.2-gigawatt AI data center in Abilene, Texas.
Under the terms of the joint venture, Crusoe in combination with funds managed by Blue Owl's Real Assets platform along with Primary Digital Infrastructure will jointly sponsor the construction of six new buildings, which will bring the center to eight buildings upon completion. Construction of the first phase, comprising two buildings and 200+ megawatts, began in June 2024 and is expected to be energized in the first half of 2025. Construction of the second phase, consisting of the six additional buildings and a total of 1.2 gigawatts, began in March 2025 and is expected to be energized in mid-2026, setting a new bar for the speed of delivery for greenfield, hyperscale digital infrastructure projects.

NMRK

Newmark Group Arranges $7.1B Construction Loan For Blue Owl Capital, Crusoe And Primary Digital Infrastructure

<a href="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/" title="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/">https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/</a>

AMZN

GOOG

GOOGL

MSFT

Update: 'Announcing Anthropic's Claude Opus 4 and Claude Sonnet 4 on Vertex AI' - Google Cloud

Citigroup analyst Alicia Yap maintains Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) with a Buy and lowers the price target from $139 to $138.

BIDU

Citigroup Maintains Buy on Baidu, Lowers Price Target to $138

Utilities ETFs are trading lower. Weakness may be due to recent strength in Treasury yields, which could drive a rotation out of income-paying sectors.

Rumors

TOST

Watching Toast, Inc.; Hearing Investor Business Daily SwingTrader Buys Stock

Alphabet shares are trading higher. The stock may be rising on continued momentum following the company's annual developer conference earlier this week, during which it unveiled the Veo 3 upgrade to its AI video generation tool.

HNGE

Hinge Health IPO Shares Open For Trade At $39.25/Share; IPO Priced At $32/Share On 13.7M Shares

Citigroup analyst Yigal Nochomovitz maintains Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Buy and lowers the price target from $49 to $41.

APLS

Citigroup Maintains Buy on Apellis Pharmaceuticals, Lowers Price Target to $41

Shares of Snowflake Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) rallied after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45553121/snowflake-q1-earnings-revenue-eps-beat-estimates-ai-data-cloud-company-sees-25-growth-ahead-shares-climb">first-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Piper Sandler On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586e4055351b9b00018beeab/brent-bracelin">Analyst Brent Bracelin</a> reiterated an Overweight rating, while raising the price target from $175 to $215.
Snowflake's total revenue surpassed $1 billion in the first quarter, driven by "another quarter of strong execution and better-than-expected contribution from new products," Bracelin said in a note. Large deal momentum continued, with the company inking two deals worth more than $100 million during the quarter, he added.
These deals contributed to Snowflake's healthy backlog metrics, with cRPO (current remaining performance obligation) accelerating to 31% year-on-year, from the previous quarter's 27%, the analyst stated. "Management has not yet witnessed any negative macro impacts, partially attributable to a more mature customer base, and even cited strong customer net adds (451 vs. 357 one year ago)," he further wrote.
Stifel On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585beadbb5a482000151d186/brad-reback">Analyst Brad Reback</a> maintained a Buy rating, while lifting the price target from $210 to $220.
Snowflake posted a strong quarter, with growth in product revenue accelerating to 4%, from 3% in the previous quarter, Reback said. This was driven by "outperformance from newer products (Snowpark, Dynamic tables), no tangible impact from the macro, and broad-based consumption strength," he added.
The company's operating margins came in better than expected, with operating expenses growing only 15% year-on-year, a sharp deceleration from 36% in the first quarter of the last fiscal year, the analyst stated. With Snowflake yet to reap "the full benefits from the R&amp;D hiring changes," the current margin gains appear sustainable, he further wrote.
JMP Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846fffaee7bf6000154d141/patrick-walravens">Analyst Patrick Walravens</a> reaffirmed a Market Outperform rating, while raising the price target from $201 to $245.
Snowflake reported total revenue of $1.04 billion, beating consensus of $1.01 billion, Walravens said. The company's non-GAAP earnings of 24 cents per share surpassed expectations of 21 cents per share, he added.
The company's second-quarter guidance came in better than expected, with product revenue of $1.035-$1.040 billion above consensus $1.021 billion, representing 25% year-on-year growth and non-GAAP operating margin of 8% ahead of consensus of 7%, the analyst stated. "Snowflake addresses a huge opportunity that is expected to double to $342B in 2028 from $152B in 2023," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Truist Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein">Analyst Joel Fishbein</a> reiterated a Buy rating, while lifting the price target from $210 to $235.
Snowflake delivered a strong beat and raise quarter, "driven by both core momentum and the adoption of new workloads," Fishbein said. Management raised their fiscal 2026 product revenue growth guidance to 25%, from their prior projection of 24%, he added.
"We did not hear signs of macro uncertainty impacting consumption on the call and believe that they are establishing the foundation of a strong go to market motion in the emerging AI landscape," the analyst further wrote.
Oppenheimer On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5937f6b185b07a0001ac364f/ittai-kidron">Analyst Ittai Kidron</a> maintained an Outperform rating, while raising the price target from $201 to $225.
Snowflake delivered strong quarterly results, driven by "broad-based demand and steady consumption trends," Kidron said. The company's total customers grew by 18.9% year-on-year to 11,578 in the quarter, he added.
"In addition, better-than-expected Snowpark and Dynamic Tables activity and strong AI adoption (5,200+ accounts) suggest that newer products are resonating with customers," the analyst wrote. He named Snowflake as a top pick.
Rosenblatt Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60081c88879cba00010420fb/blair-abernethy">Analyst Blair Abernethy</a> reaffirmed a Buy rating, while raising the price target from $205 to $210.
Snowflake reported margins of 9%, versus Rosenblatt's 5% estimate, on the back of its revenue beat and ongoing efficiency improvements, Abernethy said. Snowflake had strong renewals during the quarter, including two deals worth over $100 million each, he added.
The company's trailing NRR (net revenue retention) remained healthy, at 124%, the analyst stated. "We believe Snowflake's much improved product development cadence last year is clearly resonating with existing customers, driving increasing consumption levels," he further wrote.
Needham On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> reiterated a Buy rating, while lifting the price target from $215 to $230.
Snowflake outperformed its revenue guidance by $36.8 million and raised its full-year outlook by $45 million, Cikos said. For the second quarter, the company's revenue guidance came in $15.1 million above consensus, he added.
"Investors are hunting for high-growth companies, and we believe Snowflake&#8217;s updated FY26 Revenue outlook for 25% yr-yr growth answers the call," the analyst wrote. GenAI is likely to be "a long-term secular tailwind to Snowflake&#8217;s growth," he further stated.
SNOW Price Action: Shares of Snowflake had risen by 10.3% to $197.55 at the time of publication on Thursday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> Snowflake Jumps 8% Pre-Market After Piper Sander Hikes Price Target To $215, Calls It &#8216;High-Conviction Growth Play&#8217;</a></li>
</ul>
Photo: Shutterstock

SNOW

Snowflake Pops After Solid Quarter: Analysts See Strength In AI, New Workloads

<h3>Gainers</h3>
<ul>
<li>Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) stock moved upwards by 52.0% to $47.59 during Thursday's regular session. The company's market cap stands at $2.8 billion. The company's, Q1 earnings came out today. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares moved upwards by 28.88% to $2.32. The company's market cap stands at $40.8 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares moved upwards by 26.2% to $5.49. The company's market cap stands at $128.6 million. </li>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) stock increased by 23.66% to $3.61. The market value of their outstanding shares is at $85.8 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock moved upwards by 22.22% to $3.41. The market value of their outstanding shares is at $1.9 million. </li>
<li>Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares rose 21.85% to $72.62. The company's market cap stands at $6.7 billion. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares fell 31.9% to $6.03 during Thursday's regular session. The company's market cap stands at $107.5 million. </li>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock fell 18.62% to $1.45. The company's market cap stands at $27.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) stock fell 14.84% to $1.08. The market value of their outstanding shares is at $11.9 million. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock fell 14.59% to $0.01. The company's market cap stands at $3.2 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock decreased by 12.36% to $1.56. The market value of their outstanding shares is at $12.3 million. As per the news, the FY earnings report came out 2 days ago. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares decreased by 9.69% to $1.17. The company's market cap stands at $29.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FEBO

GNLN

KIDZ

LTRY

NTCL

SBET

YSXT

ZCMD

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) shares moved upwards by 241.8% to $7.89 during Thursday's regular session. The company's market cap stands at $368.4 million. </li>
<li>Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) stock increased by 48.15% to $24.03. The market value of their outstanding shares is at $157.6 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) stock rose 32.85% to $1.86. The company's market cap stands at $5.3 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) stock rose 27.77% to $3.91. The market value of their outstanding shares is at $3.9 million. </li>
<li>Prenetics Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRE#NASDAQ">PRE</a>) shares increased by 22.86% to $9.94. The company's market cap stands at $121.4 million. </li>
<li>Ventyx Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) stock rose 21.24% to $1.85. The market value of their outstanding shares is at $132.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock fell 45.5% to $2.46 during Thursday's regular session. The company's market cap stands at $7.4 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 31.29% to $1.28. The market value of their outstanding shares is at $24.1 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock fell 30.47% to $0.21. The company's market cap stands at $2.3 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock declined by 21.32% to $0.0. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock fell 21.04% to $0.3. The market value of their outstanding shares is at $2.3 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares declined by 15.01% to $0.01. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APVO

BMGL

EYEN

HCTI

PLRZ

VIGL

VTAK

VTYX

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock rose 26.3% to $0.9 during Thursday's regular session. The market value of their outstanding shares is at $50.0 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock moved upwards by 25.57% to $0.55. The company's market cap stands at $3.8 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) stock moved upwards by 19.96% to $0.36. </li>
<li>Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) stock moved upwards by 16.88% to $21.84. The company's market cap stands at $98.1 million. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) shares moved upwards by 15.29% to $5.05. The company's market cap stands at $65.5 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock rose 14.49% to $0.18. The market value of their outstanding shares is at $27.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares decreased by 39.8% to $6.42 during Thursday's regular session. The company's market cap stands at $1.4 billion. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) stock decreased by 19.88% to $1.37. The company's market cap stands at $101.0 million. </li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) stock decreased by 19.18% to $0.8. The market value of their outstanding shares is at $1.8 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) shares fell 15.5% to $0.6. The market value of their outstanding shares is at $31.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>EnerSys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENS#NYSE">ENS</a>) stock declined by 15.18% to $81.01. The market value of their outstanding shares is at $3.1 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock declined by 15.14% to $6.0. The market value of their outstanding shares is at $10.2 million. As per the news, the Q1 earnings report came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIR

FRGT

GPUS

JVSAR

Nuveen Insured California Premium Fund Ii

SGBX

SPWR

TISI

12 Industrials Stocks Moving In Thursday's Intraday Session

Earnings

Press Releases

Canaan Inc. Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Financing

Mawson Infrastructure Group Inc. Executes New Customer Agreement with Canaan Inc., Growing and Expanding Digital Colocation Business with Latest-Gen ASICs

Fintech

Canaan Unveils Avalon Q at Mining Disrupt 2025: a Professional-Grade Quiet Bitcoin Mining Solution for Home Use

Canaan Inc. Provides March 2025 Bitcoin Production and Mining Operation Updates

Canaan Inc. to Participate in Jefferies Power x Coin Virtual Conference

Canaan Inc. Files 2024 Annual Report on Form 20-F

Canaan Inc. to Report First Quarter 2025 Financial Results on May 20, 2025

Canaan Inc. Provides April 2025 Bitcoin Production and Mining Operation Updates

Canaan Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

Canaan Inc. Reports Unaudited First Quarter 2025 Financial Results

MIGI

Apple

AstroNova

CompoSecure

Corsair Gaming

Diebold Nixdorf Incorporated Common stock

Diebold Nixdorf

Dell Technologies Inc. Class C Common Stock

Dell Technologies

Foxx Development Holdings Inc. - Common Stock

Foxx Development Hldgs

Hewlett Packard Enterprise Company Common Stock

Hewlett Packard

Immersion

IonQ

Eastman Kodak

NetApp

One Stop Systems

CPI Card

Pure Storage

Quantum

Super Micro Computer, Inc. - Common Stock

Super Micro Computer

SanDisk

Sonim Technologies

Seagate Technology Holdings PLC - Ordinary Shares (Ireland)

Seagate Tech Hldgs

TransAct Technologies Incorporated - Common Stock

Transact Technologies

Turtle Beach

Western Digital Corporation - Common Stock

Western Digital

Xerox Holdings Corporation - Common Stock

Xerox Holdings

Rosenblatt

Benchmark

HC Wainwright & Co.

Compass Point

B. Riley Securities

APLD

BITF

BTBT

BTCT

BTDR

CLSK

CNCK

COIN

HIVE

MARA

MSTR

RIOT

Shares of crypto-linked stocks and Bitcoin miners are trading higher after Bitcoin reached a new all-time high, rising above $110,000.

Comments

Canaan

空売り

Canaan (NASDAQ:CAN) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル